Cytodyn Inc (CYDY)

[Borel Fields]

Not true in these times, IMO. I've been through the delays you describe (got a JAMA co-authorship myself), but back then reviewing a paper was never anyone's priority.

Today, say Nature called (ha-ha) saying they want you to review a paper that could change COVID-19 treatment. After finishing nature's call, what else besides responding to Nature's call would be more important in your day - 24 hours a day?

Also, (1) these major journals are competing for major COVID scoops - Lancet even bothered to publish negative results on RVD from an underpowered study, and (2) prelim versions of Patterson's paper have been making the rounds in medical circles (again, ha-ha) for weeks.

Here's an alternative, just speculation, about why a Nature paper could take another week. Nature includes opinions and commentary - they could be turning this into a multi-dimensional piece. Again, just could be.